Heron Therapeutics reports positive study results By: MarketMinute.com Stock News May 29, 2015 at 12:27 PM EDT Heron Therapeutics Inc. (Nasdaq: HRTX) reported positive results from a Phase 3 MAGIC study of SUSTOL sending the stock price soaring $6.86 to $19.21. Related Stocks: Heron Therapeutics